WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Results 1-10 of 59,409 for Criteria: Office(s):all Language:FR Stemming: true maximize
préc. 1 2 3 4 5 6 7 8 9 10 suiv.
Page: / 5941  Go >
RSS icon map icon

Analysis
Analysis

List Length
No translation
NoCtrTitlePubDateInt.ClassAppl.NoApplicantInventor
1. WOWO/2014/120981 - COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS07.08.2014
A61K 9/16
PCT/US2014/013953GILEAD PHARMASSET LLCCHAL, Ben
Disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir.

2. WOWO/2014/101970 - A METHOD FOR VEHICLE IDENTIFICATION AND A SYSTEM FOR VEHICLE IDENTIFICATION03.07.2014
G06K 9/32
PCT/EP2012/077109INSTYTUT BADAWCZY DROG I MOSTOWKARKOWSKI, Michal
A method for vehicle identification to determine at least one vehicle characteristic, comprising: obtaining an input image (301) of the vehicle from an image source (101); normalisation of the input image (301 ) of the vehicle in a normalisation unit (103, 104) to obtain a normalized image; determining the vehicle characteristic in a classification unit (111, 112) by comparing parameters of a normalised image obtained in a parametrisation unit (107, 108) with parameters of reference images obtained from a reference database (113, 114). Normalisation in the normalisation unit (103, 104) comprises the steps of: detecting a registration plate area (303) within the input image (301); processing the input image (301) basing on normalisation attributes defining at least one scaling coefficient (znorm, anorm, vnorm); choosing from the scaled image (307) a Rol area (308) of a normalised size and location dependent on the location of the registration plate area (303); and presenting data from the Rol area (308) as a normalised image (311).

3. WOWO/2014/090418 - CRYOGENIC DEVICE19.06.2014
A61F 7/00
PCT/EP2013/061068SHUPPO, VladimirSHUPPO, Vladimir
Cryogenic device for carrying out cryotherapy on the entire body of a patient, the cryogenic device comprising: a treatment cabin (1) for taking up a patient, the treatment cabin (1) having closed walls, a closed roof and a door for entering the treatment cabin (1); a cold treatment gas preparation and distribution system for preparing a cold gas mixture and introducing it into the treatment cabin (1); and a control system (4) for controlling the introduction of cold treatment gas from the cold treatment gas preparation and distribution system into the treatment cabin (1), wherein the treatment cabin (1) further comprises a breathing window (7) for allowing a patient located inside the treatment cabin (1) to breath air from outside of the treatment cabin (1), the breathing window (7) comprising sealing means for allowing a tight contact between the breathing window (7) and the face of the patient.

4. WOWO/2014/082286 - RAFAMYCIN ANALOGS AND METHODS FOR MAKING SAME05.06.2014
C07D 498/18
PCT/CN2012/085631HANGZHOU ZYLOX PHARMA CO., LTD.WANG, Bing
A semi-synthetic rapamycin analog with a triazole moiety or a pharmaceutically acceptable salt or prodrug thereof, is a broad-spectrum cytostatic agent and a m TOR inhibitor, and is useful in the treatment of various cancers, or tumors in organs such as kidney, liver, breast, head and neck, lung, prostate, and restenosis in coronary arteries, peripheral arteries, and arteries in the brain, immune and autoimmune diseases. Also disclosed are fungal growth-, restenosis-, post- transplant tissue rejection- and immune- and autoimmune disease- inhibiting compositions and a method of inhibiting cancer, fungal growth, restenosois, post-transplant tissue rejection, and immune and autoimmune disease in a mammal. One particular preferred application of such triazole-moiety containing rapamycin analog is in treating renal carcinoma, lung cancer, colon cancer, and breast cancers wherein potency of the drug, its half-life, tissue distribution properties, and its pharmacokinetic properties including bioavailability through oral and intravenous routes are essential to the clinical outcomes.

5. WOWO/2014/084878 - SENSOR FUSION ALGORITHM05.06.2014
G06F 3/00
PCT/US2013/028488MICROSOFT CORPORATIONPEREK, David R.
Sensor fusion algorithm techniques are described. In one or more embodiments, behaviors of a host device and accessory devices are controlled based upon an orientation of the host device and accessory devices, relative to one another. A combined spatial position and/or orientation for the host device may be obtained based on raw measurements that are obtained from at least two different types of sensors. In addition, a spatial position and/or orientation for an accessory device is ascertained using one or more sensors of the accessory device. An orientation (or position) of the accessory device relative to the host computing device may then be computed based on the combined spatial position/orientation for the host computing device and the ascertained spatial position/orientation for the accessory device. The relative orientation that is computed may then be used in various ways to control behaviors of the host computing device and/or accessory device.

6. WOWO/2014/079020 - PHARMACEUTICAL COMPOSITION USED FOR REDUCING DAMAGE CAUSED BY FREE RADICALS30.05.2014
A61K 47/48
PCT/CN2012/085066ORIGINAL BIOMEDICALS CO., LTD.CHEN, Chia-Hung
A pharmaceutical composition used for reducing the damage caused by free radicals is disclosed. The composition comprises at least a metal or its ions, at least a drug or an antioxidant that is carrier-protected/modified, and a drug carrier. Said carrier helps to preserve the anti-oxidative activity, and hence, prevents the decrease of the effect of the antioxidant against free radicals produced in the environment or body fluids and prolongs protection, and may be used for reducing damage caused by radiation and adverse effects induced by chemotherapeutic drugs.

7. WOWO/2014/070291 - INFLATABLE SOLAR POWERED LAMP08.05.2014
F21L 4/08
PCT/US2013/056182MPOWERD, INC.SNYDER, Jason Alan
A solar powered lamp is provided with flat ends and a translucent flexible housing, such that the housing can be inflated to form a free standing cylinder. A solar panel faces outward on one of the flat ends for recharging a low-profile rechargeable battery which, under the control of a printed circuit panel, powers an array of LEDs, which point into the lamp housing. Reflective surfaces, facing each other on opposite inside end walls of the lamp, maximize the diffusion of light from the LEDs. The lamp is aa durable, portable, long light lighting solution for those who live off the electric power grid, victims of disaster, and the like.

8. WOWO/2014/063650 - SELF-EXPANDING STENT01.05.2014
A61F 2/90
PCT/CN2013/085949ZHEJIANG ZYLOX MEDICAL DEVICE CO., LTD.ZHAO, Jonathon Z.
A self-expanding stent (10), which is created by laser-cutting a Nitinol alloy tubing. A strut pattern of the stent (10) is formed from a continuous helical band that proceeds circumferentially and longitudinally along the length of the stent (10). The helices are formed by repetitions of sinusoidal forms, with a bridge (12) linking the apexes of struts on neighboring adjacent rows directly opposite of each other, for every 4-8 apexes. The linking bridges are substantially straight such that non off-setting pitches is created at the two connected apexes, resulting in a substantially diamond space (71,72,73) between adjacent rows of the struts, instead of a substantially interdigitated space. The strut repetitions are substantially sinusoidal or in a zigzag fashion. The bridges link the apexes of the repetitions forms directly on adjacent rows of struts. The ends of the stent (10) may be formed by using a transition zone on each end that employs gradually decreasing lengths of struts to complete the transition to an even end. The stent (10) made with this pattern and a suitable material has an optimal combination of torsional flexibility, high radial strength and good resistance to longitudinal compression.

9. WOWO/2014/064540 - WATER TREATMENT DEVICE AND METHOD01.05.2014
C02F 1/48
PCT/IB2013/003042HOU, HongjiHOU, Hongji
A water treatment system, comprising a plurality of pipes, each of the plurality of pipes formed of a rare earth metal alloy and configured for water passage therethrough in a water flow direction wherein excitation of electrons in the rare earth metal alloy of at least one pipe in the plurality of pipes forms an electric field along the at least one pipe, the electric field having a direction perpendicular to the water flow direction in the at least one pipe, and a plurality of permanent magnets configured to create a magnetic field along the at least one pipe, the magnetic field having a direction perpendicular to the water flow direction of the at least one pipe, wherein the electric field and the magnetic field are configured to break at least some hydrogen bonds between water molecules of water passing through the at least one pipe.

10. WOWO/2014/061024 - A MULTI-TECHNOLOGY PRINTING SYSTEM24.04.2014
B41J 2/00
PCT/IL2013/050845PHOTON JET LTDBATT, Aryeh
A system for performing substrateless and/or local donor Laser Induced Forward Transfer (LIFT), comprising a reservoir (9) comprising at least one opening; and an energy source configured to deliver energy to a donor material within said reservoir. In preferred embodiments of the invention, the energy source is a pulsed laser. This system enables deposition of material by LIFT without any need for a donor substrate. Methods of substrateless and local donor LIFT are also disclosed.


Results 1-10 of 59,409 for Criteria: Office(s):all Language:FR Stemming: true
préc. 1 2 3 4 5 6 7 8 9 10 suiv.